GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Esperion Therapeutics Inc. (ESPR) [hlAlert]

Rating:
Sell ESPR
up 109.61 %

Esperion Therapeutics Inc. (ESPR) rated Sell with price target $40 by Chardan Capital Markets

Posted on: Friday,  Aug 7, 2015  8:25 AM ET by Chardan Capital Markets

Chardan Capital Markets rated Sell Esperion Therapeutics Inc. (NASDAQ: ESPR) on 08/07/2015. Previously Chardan Capital Markets rated Sell Esperion Therapeutics Inc. (NASDAQ: ESPR)
on 05/22/2015., when the stock price was $109.02. Since then, Esperion Therapeutics Inc. has lost 52.29% as of 01/05/2016's recent price of $52.01.
If you would have followed the previous Chardan Capital Markets's recommendation on ESPR, you would have gained 109.61% of your investment in 228 days.



Chardan Capital Markets
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/30/2015 8:25 AM Hold
None
20.11 18.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/31/2015 9:25 AM Sell
None
50.90 36.00
8/7/2015 8:25 AM Sell
None
53.88 40.00
5/25/2015 8:25 AM Sell
None
55.00
5/22/2015 8:25 AM Sell
None
109.02 55.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy